Literature DB >> 2569739

Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor.

D Metcalf1, D P Gearing.   

Abstract

Cells of the murine hemopoietic cell line FDC-P1 were multiply infected with a retroviral construct containing cDNA encoding the leukemia inhibitory factor (LIF) to produce cells secreting high levels of LIF. Injection of these cells to unirradiated or irradiated syngeneic DBA/2 mice resulted in animals engrafted with LIF-producing cells in the marrow, spleen, and lymph nodes and with elevated serum LIF levels. These mice developed within 12-70 days a fatal syndrome characterized by cachexia, excess new bone formation, calcification in heart and skeletal muscle, pancreatitis, thymus atrophy, and abnormalities in the adrenal cortex and ovarian corpora lutea. Injection of mice with control FDC-P1 cells led to comparable organ engraftment, but the mice developed none of these lesions. The observations suggest that LIF may be a potent cachexia-inducing agent and may have marked effects on osteoblasts and calcium metabolism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569739      PMCID: PMC297748          DOI: 10.1073/pnas.86.15.5948

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

Review 2.  Tumor necrosis factor alpha: a multifaceted peptide hormone.

Authors:  M G Rosenblum; N J Donato
Journal:  Crit Rev Immunol       Date:  1989       Impact factor: 2.214

3.  Complete sequence of murine myeloid leukaemia inhibitory factor (LIF).

Authors:  D P Gearing; J A King; N M Gough
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

4.  Specific binding of murine leukemia inhibitory factor to normal and leukemic monocytic cells.

Authors:  D J Hilton; N A Nicola; D Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

5.  A model system for leukemic transformation of immortalized hemopoietic cells in irradiated recipient mice.

Authors:  U Dührsen; D Metcalf
Journal:  Leukemia       Date:  1988-06       Impact factor: 11.528

6.  Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells.

Authors:  R L Williams; D J Hilton; S Pease; T A Willson; C L Stewart; D P Gearing; E F Wagner; D Metcalf; N A Nicola; N M Gough
Journal:  Nature       Date:  1988-12-15       Impact factor: 49.962

7.  Purification of a murine leukemia inhibitory factor from Krebs ascites cells.

Authors:  D J Hilton; N A Nicola; D Metcalf
Journal:  Anal Biochem       Date:  1988-09       Impact factor: 3.365

8.  Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells.

Authors:  J F Moreau; D D Donaldson; F Bennett; J Witek-Giannotti; S C Clark; G G Wong
Journal:  Nature       Date:  1988-12-15       Impact factor: 49.962

9.  A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor.

Authors:  G R Johnson; T J Gonda; D Metcalf; I K Hariharan; S Cory
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

10.  Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF).

Authors:  D P Gearing; N M Gough; J A King; D J Hilton; N A Nicola; R J Simpson; E C Nice; A Kelso; D Metcalf
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

View more
  56 in total

1.  JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.

Authors:  Andrea Bonetto; Tufan Aydogdu; Xiaoling Jin; Zongxiu Zhang; Rui Zhan; Leopold Puzis; Leonidas G Koniaris; Teresa A Zimmers
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-05       Impact factor: 4.310

Review 2.  Hypothalamic mechanisms in cachexia.

Authors:  Aaron J Grossberg; Jarrad M Scarlett; Daniel L Marks
Journal:  Physiol Behav       Date:  2010-03-25

3.  Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow.

Authors:  S C Lin; T Yamate; Y Taguchi; V Z Borba; G Girasole; C A O'Brien; T Bellido; E Abe; S C Manolagas
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

4.  Cytokines, hematopoiesis, osteoclastogenesis, and estrogens.

Authors:  S C Manolagas; R L Jilka
Journal:  Calcif Tissue Int       Date:  1992-03       Impact factor: 4.333

5.  Expression and function of leukaemia inhibitory factor and its receptor in normal and regenerating rat pancreas.

Authors:  S De Breuck; L Baeyens; L Bouwens
Journal:  Diabetologia       Date:  2005-12-21       Impact factor: 10.122

Review 6.  Transgenic mice in the study of cytokine function.

Authors:  J Taverne
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

7.  Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice.

Authors:  P M Waring; L J Waring; T Billington; D Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Arcuate nucleus proopiomelanocortin neurons mediate the acute anorectic actions of leukemia inhibitory factor via gp130.

Authors:  Aaron J Grossberg; Jarrad M Scarlett; XinXia Zhu; Darren D Bowe; Ayesha K Batra; Theodore P Braun; Daniel L Marks
Journal:  Endocrinology       Date:  2009-12-16       Impact factor: 4.736

9.  Systemic administration of ciliary neurotrophic factor induces cachexia in rodents.

Authors:  J T Henderson; N A Seniuk; P M Richardson; J Gauldie; J C Roder
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

10.  Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis.

Authors:  M Lotz; T Moats; P M Villiger
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.